REPAGLINIDE — all Canadian products
27 DINs
12 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is REPAGLINIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02424258 | AURO-REPAGLINIDE | AURO PHARMA INC | Tablet | Oral | REPAGLINIDE 0.5 MG | Marketed | |
| 02424274 | AURO-REPAGLINIDE | AURO PHARMA INC | Tablet | Oral | REPAGLINIDE 2 MG | Marketed | |
| 02424266 | AURO-REPAGLINIDE | AURO PHARMA INC | Tablet | Oral | REPAGLINIDE 1 MG | Marketed | |
| 02354926 | JAMP REPAGLINIDE | JAMP PHARMA CORPORATION | Tablet | Oral | REPAGLINIDE 0.5 MG | Marketed | |
| 02354934 | JAMP REPAGLINIDE | JAMP PHARMA CORPORATION | Tablet | Oral | REPAGLINIDE 1 MG | Marketed | |
| 02354942 | JAMP REPAGLINIDE | JAMP PHARMA CORPORATION | Tablet | Oral | REPAGLINIDE 2 MG | Marketed | |
| 02415984 | REPAGLINIDE | PRO DOC LIMITEE | Tablet | Oral | REPAGLINIDE 2 MG | Marketed | |
| 02415968 | REPAGLINIDE | PRO DOC LIMITEE | Tablet | Oral | REPAGLINIDE 0.5 MG | Marketed | |
| 02415976 | REPAGLINIDE | PRO DOC LIMITEE | Tablet | Oral | REPAGLINIDE 1 MG | Marketed | |
| 02357461 | SANDOZ REPAGLINIDE | SANDOZ CANADA INCORPORATED | Tablet | Oral | REPAGLINIDE 1 MG | Marketed | |
| 02357453 | SANDOZ REPAGLINIDE | SANDOZ CANADA INCORPORATED | Tablet | Oral | REPAGLINIDE 0.5 MG | Marketed | |
| 02357488 | SANDOZ REPAGLINIDE | SANDOZ CANADA INCORPORATED | Tablet | Oral | REPAGLINIDE 2 MG | Marketed | |
| 02321491 | ACT REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 2 MG | Dormant | |
| 02321483 | ACT REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 1 MG | Dormant | |
| 02321475 | ACT REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 0.5 MG | Dormant | |
| 02355671 | APO-REPAGLINIDE | APOTEX INC | Tablet | Oral | REPAGLINIDE 1.0 MG | Dormant | |
| 02355698 | APO-REPAGLINIDE | APOTEX INC | Tablet | Oral | REPAGLINIDE 2.0 MG | Dormant | |
| 02355663 | APO-REPAGLINIDE | APOTEX INC | Tablet | Oral | REPAGLINIDE 0.5 MG | Dormant | |
| 02239924 | GLUCONORM 0.5MG | NOVO NORDISK CANADA INC | Tablet | Oral | REPAGLINIDE 0.5 MG | Cancelled Post Market | |
| 02239925 | GLUCONORM 1.0MG | NOVO NORDISK CANADA INC | Tablet | Oral | REPAGLINIDE 1.0 MG | Cancelled Post Market | |
| 02239926 | GLUCONORM 2.0MG | NOVO NORDISK CANADA INC | Tablet | Oral | REPAGLINIDE 2.0 MG | Cancelled Post Market | |
| 02373297 | MYLAN-REPAGLINIDE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | REPAGLINIDE 2 MG | Cancelled Pre Market | |
| 02373289 | MYLAN-REPAGLINIDE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | REPAGLINIDE 1 MG | Cancelled Pre Market | |
| 02373270 | MYLAN-REPAGLINIDE | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | REPAGLINIDE 0.5 MG | Cancelled Pre Market | |
| 02366363 | TEVA-REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 2 MG | Cancelled Pre Market | |
| 02366355 | TEVA-REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 1 MG | Cancelled Pre Market | |
| 02366347 | TEVA-REPAGLINIDE | TEVA CANADA LIMITED | Tablet | Oral | REPAGLINIDE 0.5 MG | Cancelled Pre Market |
Browse other molecules: